Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Share Holder Equity 2010-2023 | SIGA

Siga Technologies share holder equity from 2010 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
  
Siga Technologies Annual Share Holder Equity
(Millions of US $)
2023 $197
2022 $170
2021 $174
2020 $130
2019 $98
2018 $103
2017 $-323
2016 $-287
2015 $-284
2014 $-247
2013 $17
2012 $28
2011 $41
2010 $12
2009 $7
Siga Technologies Quarterly Share Holder Equity
(Millions of US $)
2023-12-31 $197
2023-09-30 $124
2023-06-30 $124
2023-03-31 $162
2022-12-31 $170
2022-09-30 $173
2022-06-30 $140
2022-03-31 $168
2021-12-31 $174
2021-09-30 $107
2021-06-30 $117
2021-03-31 $123
2020-12-31 $130
2020-09-30 $113
2020-06-30 $94
2020-03-31 $88
2019-12-31 $98
2019-09-30 $103
2019-06-30 $103
2019-03-31 $106
2018-12-31 $103
2018-09-30 $52
2018-06-30 $-341
2018-03-31 $-335
2017-12-31 $-323
2017-09-30 $-313
2017-06-30 $-303
2017-03-31 $-296
2016-12-31 $-287
2016-09-30 $-313
2016-06-30 $-304
2016-03-31 $-295
2015-12-31 $-284
2015-09-30 $-265
2015-06-30 $-259
2015-03-31 $-253
2014-12-31 $-247
2014-09-30 $-228
2014-06-30 $12
2014-03-31 $14
2013-12-31 $17
2013-09-30 $19
2013-06-30 $23
2013-03-31 $26
2012-12-31 $28
2012-09-30 $32
2012-06-30 $34
2012-03-31 $38
2011-12-31 $41
2011-09-30 $46
2011-06-30 $43
2011-03-31 $11
2010-12-31 $12
2010-09-30 $8
2010-06-30 $4
2010-03-31 $7
2009-12-31 $7
2009-09-30 $-11
2009-06-30 $-13
2009-03-31 $-6
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.614B $0.140B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.141B 28.83
Chugai Pharmaceutical (CHGCY) Japan $51.291B 22.93
Takeda Pharmaceutical (TAK) Japan $41.364B 6.70
Merck (MKGAF) Germany $21.368B 20.16
Astellas Pharma (ALPMY) Japan $17.264B 27.26
Sandoz Group AG (SDZNY) Switzerland $14.500B 0.00
Shionogi (SGIOY) Japan $14.029B 12.14
Neurocrine Biosciences (NBIX) United States $13.708B 56.93
United Therapeutics (UTHR) United States $11.103B 11.89
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.639B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.768B 6.86
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.819B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.236B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.868B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.943B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.710B 0.00
Summit Therapeutics (SMMT) United States $2.491B 0.00
Indivior (INDV) United States $2.378B 11.27
Corcept Therapeutics (CORT) United States $2.312B 23.38
Dyne Therapeutics (DYN) United States $2.042B 0.00
PTC Therapeutics (PTCT) United States $1.953B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.914B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.840B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.811B 10.73
Evotec AG (EVO) Germany $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.732B 17.90
Avadel Pharmaceuticals (AVDL) Ireland $1.614B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.468B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.265B 11.88
Soleno Therapeutics (SLNO) United States $1.248B 0.00
4D Molecular Therapeutics (FDMT) United States $1.204B 0.00
Pacira BioSciences (PCRX) United States $1.186B 11.81
Xencor (XNCR) United States $1.185B 0.00
Collegium Pharmaceutical (COLL) United States $1.172B 7.21
Cronos Group (CRON) Canada $0.955B 0.00
Cassava Sciences (SAVA) United States $0.940B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.896B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
USANA Health Sciences (USNA) United States $0.830B 13.07
Sage Therapeutics (SAGE) United States $0.817B 0.00
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
ARS Pharmaceuticals (SPRY) United States $0.781B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.704B 0.00
Ocular Therapeutix (OCUL) United States $0.650B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
ProKidney (PROK) United States $0.622B 0.00
Savara (SVRA) United States $0.615B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.579B 0.00
Lyell Immunopharma (LYEL) United States $0.561B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
OmniAb (OABI) United States $0.519B 0.00
Altimmune (ALT) United States $0.510B 0.00
Exscientia (EXAI) United Kingdom $0.482B 0.00
Korro Bio (KRRO) United States $0.470B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.444B 0.00
KalVista Pharmaceuticals (KALV) United States $0.443B 0.00
Tourmaline Bio (TRML) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Lexeo Therapeutics (LXEO) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.383B 0.00
Esperion Therapeutics (ESPR) United States $0.377B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.44
Harrow (HROW) United States $0.354B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.352B 0.00
Bioventus (BVS) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.322B 0.00
Lyra Therapeutics (LYRA) United States $0.309B 0.00
Organogenesis (ORGO) United States $0.302B 57.12
Aquestive Therapeutics (AQST) United States $0.288B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.282B 0.00
Nanobiotix S.A (NBTX) France $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.271B 0.00
Black Diamond Therapeutics (BDTX) United States $0.268B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.252B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.226B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Prelude Therapeutics (PRLD) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Telomir Pharmaceuticals (TELO) United States $0.201B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Regulus Therapeutics (RGLS) United States $0.149B 0.00
Incannex Healthcare (IXHL) Australia $0.146B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.95
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 2.54
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
GlycoMimetics (GLYC) United States $0.110B 0.00
OptiNose (OPTN) United States $0.102B 0.00
FibroGen (FGEN) United States $0.101B 0.00
Eliem Therapeutics (ELYM) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
AlloVir (ALVR) United States $0.092B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.075B 6.04
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.83
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Unicycive Therapeutics (UNCY) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Nutriband (NTRB) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Surrozen (SRZN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.024B 11.33
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.04
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.39